Skip to main content
Erschienen in: Journal of Neurology 11/2006

01.11.2006 | ORIGINAL COMMUNICATION

Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI

verfasst von: David B. Olsen, Peter Gideon, Tina Dysgaard Jeppesen, John Vissing

Erschienen in: Journal of Neurology | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Abstract

Using MRI, we evaluated the degree of involvement of muscles in the lower extremities of 18 unselected patients with facioscapulohumeral muscular dystrophy (FSHD). Findings were correlated with fragment size of the mutated gene, age, disease duration and muscle power.
Most affected muscles were the hamstrings followed by the tibialis anterior and the medial gastrocnemius. The vastus-, gluteal- and peroneal muscles were the most unaffected, and the psoas muscle did not show evidence of involvement in any of the investigated subjects. Asymmetric involvement was evident in 15% of the investigated muscles on MRI and 6% on manual muscle strength testing. MRI findings in muscle tended to correlate with disease duration (r = 0.49; p < 0.05), but not with gene fragment size or age. MRI disclosed involvement of muscles performing hip flexion and ankle dorsal flexion that could not be detected by manual muscle strength testing. Otherwise, there was a close correlation (≈ r = 0.75; p < 0.0001) between muscle strength and MRI severity score for other muscle groups.
The present study shows that MRI may disclose muscle involvement in FSHD that is not apparent on manual muscle testing, and suggests that MRI of muscle may be an important assessment tool in clinical trials involving patients with FSHD.
Literatur
1.
Zurück zum Zitat Kilmer DD, Abresch RT, McCrory MA, Carter GT, Fowler WM Jr, Johnson ER, McDonald CM (1995) Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil. 74(5 Suppl):S131–139CrossRefPubMed Kilmer DD, Abresch RT, McCrory MA, Carter GT, Fowler WM Jr, Johnson ER, McDonald CM (1995) Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil. 74(5 Suppl):S131–139CrossRefPubMed
3.
Zurück zum Zitat Kreigbaum E, barthels KM. Biomechanics. A qualitative approach for studying human movement. 4th edn. Allyn and Bacon 1996:pp 595–601 Kreigbaum E, barthels KM. Biomechanics. A qualitative approach for studying human movement. 4th edn. Allyn and Bacon 1996:pp 595–601
4.
Zurück zum Zitat Lamminen AE (1990) Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 63:946–950PubMedCrossRef Lamminen AE (1990) Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 63:946–950PubMedCrossRef
5.
Zurück zum Zitat Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, Harper PS, Upadhyaya M (1995) Correlation between fragment size at D4F10S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-fascioscapulohumeral muscular dystrophy (FSHDD). Hum Mol Genet 4:951–958PubMed Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, Harper PS, Upadhyaya M (1995) Correlation between fragment size at D4F10S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-fascioscapulohumeral muscular dystrophy (FSHDD). Hum Mol Genet 4:951–958PubMed
6.
Zurück zum Zitat Medical Research Council. Aids to the investigation of peripheral nerve injuries. London: Her Majesty’s Stationary Office 1976 Medical Research Council. Aids to the investigation of peripheral nerve injuries. London: Her Majesty’s Stationary Office 1976
7.
Zurück zum Zitat Olsen DB, Ørngreen MC, Vissing J (2005) Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 64:1064–1066PubMed Olsen DB, Ørngreen MC, Vissing J (2005) Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 64:1064–1066PubMed
8.
Zurück zum Zitat Ozsarlak O, Schepens E, Parizel PM, Van Goethem JW, Vanhoenacker F, De Schepper AM, Martin JJ (2001) Hereditary neuromuscular diseases. EurJ Radiol 40:184–197CrossRef Ozsarlak O, Schepens E, Parizel PM, Van Goethem JW, Vanhoenacker F, De Schepper AM, Martin JJ (2001) Hereditary neuromuscular diseases. EurJ Radiol 40:184–197CrossRef
9.
Zurück zum Zitat Phoeni J, Betal D, Roberts N, Helliwell TR, Edwards RHT (1996) Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve 19:302–310CrossRef Phoeni J, Betal D, Roberts N, Helliwell TR, Edwards RHT (1996) Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve 19:302–310CrossRef
10.
Zurück zum Zitat Ricci E, Galluzzi G, Deidda G, Cacurri S, Colantoni L, Merico B, Piazzo N, Servidei S, Vigneti E, Pasceri V, Silvestri G, Mirabella M, Mangiola F, Tonali P, Felicetti L (1999) Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45:751–757CrossRefPubMed Ricci E, Galluzzi G, Deidda G, Cacurri S, Colantoni L, Merico B, Piazzo N, Servidei S, Vigneti E, Pasceri V, Silvestri G, Mirabella M, Mangiola F, Tonali P, Felicetti L (1999) Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45:751–757CrossRefPubMed
11.
Zurück zum Zitat Tawil R, Figlewicz DA, Griggs RC, Weiffenbach B (1998) Fascioscapulohumeral Dystrophy: A distinct regional myopathy with a novel molecular pathogenesis. Ann Neurol 43:279–282CrossRefPubMed Tawil R, Figlewicz DA, Griggs RC, Weiffenbach B (1998) Fascioscapulohumeral Dystrophy: A distinct regional myopathy with a novel molecular pathogenesis. Ann Neurol 43:279–282CrossRefPubMed
12.
Zurück zum Zitat Tawil R, Griggs RC. In: Karpati G, Hilton-Jones D, Griggs RC, (eds) Disorders of voluntary muscle; 7th edn. Cambridge University Press, 2001:464–470 Tawil R, Griggs RC. In: Karpati G, Hilton-Jones D, Griggs RC, (eds) Disorders of voluntary muscle; 7th edn. Cambridge University Press, 2001:464–470
13.
Zurück zum Zitat Upadhyaya M, Cooper DN (2002) Molecular diagnosis of facioscapulohumeral muscular dystrophy. E pert Rev Mol Diagn 2:160–171CrossRef Upadhyaya M, Cooper DN (2002) Molecular diagnosis of facioscapulohumeral muscular dystrophy. E pert Rev Mol Diagn 2:160–171CrossRef
14.
Zurück zum Zitat Wijmenga C, Frants RR, Brouwer OF, Moerer P, Weber JL, Padberg GW (1990) Location of the fascioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 336:651–653CrossRefPubMed Wijmenga C, Frants RR, Brouwer OF, Moerer P, Weber JL, Padberg GW (1990) Location of the fascioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 336:651–653CrossRefPubMed
Metadaten
Titel
Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI
verfasst von
David B. Olsen
Peter Gideon
Tina Dysgaard Jeppesen
John Vissing
Publikationsdatum
01.11.2006
Erschienen in
Journal of Neurology / Ausgabe 11/2006
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-006-0230-z

Weitere Artikel der Ausgabe 11/2006

Journal of Neurology 11/2006 Zur Ausgabe

OriginalPaper

ENS COMMUNICATIONS

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.